GlassScriptPhysician profile
Michael T Tucciarone
NPI 1427267525
$19,967.38
in general payments reported to CMS, 2019-2025
39 companies · $6,962 in 2025
The $6,962 reported for 2025 was more than what 86% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,482 · 2020: $139 · 2021: $1,087 · 2022: $2,615 · 2023: $1,591 · 2024: $5,091 · 2025: $6,962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,908 · Travel and Lodging: $5,737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,907.79 |
| Travel and Lodging | $5,736.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $5,997.84 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Inspiris Resilia Aortic Valve |
| Boston Scientific Corporation | $2,907.89 | 2019-2025 | Versacross Access Solution, Avvigo Guidance System, Synergy |
| Medtronic, INC. | $2,754.64 | 2022-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan |
| Abiomed | $1,985.85 | 2019-2025 | Impella |
| Abbott Laboratories | $978.90 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Esprit, Cardiomems |
| Inari Medical, INC. | $963.60 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $863.69 | 2019-2021 | |
| Amgen INC. | $578.55 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $307.22 | 2024-2025 | Verquvo, Winrevair |
| Imperative Care, INC | $261.42 | 2023-2025 | Symphony Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.46 | 2024-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $235.32 | 2021-2025 | Lifevest |
| Stryker Corporation | $187.72 | 2025 | Artix Mt, Flowtriever |
| Intact Vascular, INC. | $175.38 | 2019 | |
| Novartis Pharmaceuticals Corporation | $142.36 | 2024-2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $134.12 | 2021 | |
| Alnylam Pharmaceuticals INC. | $126.35 | 2024-2025 | Onpattro, Amvuttra |
| Kiniksa Pharmaceuticals International, Plc | $105.80 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $105.23 | 2023-2025 | |
| Medtronic Vascular, INC. | $91.41 | 2019 | |
| Cordis US Corp. | $84.16 | 2023-2025 | Mynx Control Venous, Mynx Control, Mynx Venous Vcd |
| Pfizer INC. | $82.09 | 2022-2025 | |
| Heartflow, INC. | $79.05 | 2023-2025 | Ffrct |
| Kestra Medical Technology Services, INC. | $63.99 | 2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $63.38 | 2021-2024 | Xarelto |
| Chiesi USA, INC. | $60.32 | 2023-2025 | Kengreal |
| Astrazeneca Pharmaceuticals LP | $57.19 | 2019-2025 | Farxiga |
| Novo Nordisk INC | $42.41 | 2024-2025 | Wegovy |
| Teleflex LLC | $39.15 | 2019-2023 | Langston |
| Philips North America LLC | $36.82 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $35.10 | 2024 | Opsumit |
| Shockwave Medical, INC | $31.95 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.38 | 2024-2025 | Eliquis, Camzyos |
| Cvrx, INC. | $25.01 | 2025 | Barostim Neo System |
| Tactile Systems Technology INC | $21.59 | 2025 | Flexitouch Plus, Nimbl |
| Cardiva Medical, INC. | $21.44 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Siemens Medical Solutions USA, INC. | $17.05 | 2022 | |
| Esperion Therapeutics, INC. | $15.18 | 2025 | Nexletol |
| Veryan Medical Incorporated | $14.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tucciarone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.